MAM
BBIO icon

Marquette Asset Management’s BridgeBio Pharma BBIO Stock Holding History

Marquette Asset Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$527 Hold
8
– – ﹤0.01% 739
2026
Q2 		$596 Sell
8
-19
-70% -$1.33K ﹤0.01% 791
2026
Q1 		$2.01K Buy
27
+19
+238% +$1.38K ﹤0.01% 543
2025
Q4 		$612 Buy
+8
New +$525 ﹤0.01% 607

Other funds holding BBIO

CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Marquette Asset Management's BBIO Position: Q3 2026 in Review

Marquette Asset Management held its BridgeBio Pharma (BBIO) position steady in Q3 2026 at 8 shares worth $527. The position accounts for ﹤0.01% of the portfolio, ranked #739.

Marquette Asset Management first reported a position in BBIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.01K in Q1 2026. 12 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Marquette Asset Management held 8 shares of BridgeBio Pharma worth $527 as of Q3 2026.
  • Marquette Asset Management left its BridgeBio Pharma share count unchanged in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of Marquette Asset Management's portfolio in Q3 2026, its #739 holding.
  • Marquette Asset Management first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 4 quarters since.
  • Marquette Asset Management's BridgeBio Pharma position peaked at $2.01K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.